# Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding

> **NCT00567216** · PHASE4 · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 120 (estimated)

## Conditions studied

- Liver Cirrhosis and Hepatoma.
- Gastric Variceal Bleeding

## Interventions

- **DRUG:** Nadolol

## Key facts

- **NCT ID:** NCT00567216
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2010-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567216, "Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00567216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*